Ninja-family protein 5 Antibody

What is NINJA-family protein 5 and what role does it play in plant signaling?

NINJA-family proteins are important components of the jasmonate signaling pathway in plants. NINJA (Novel INteractor of JAZ) connects the jasmonate ZIM-domain (JAZ) repressor proteins to the Groucho/Tup1-type co-repressor TOPLESS (TPL) and TPL-related proteins (TPRs) . While the search results don't specifically detail NINJA-family protein 5, the NINJA protein family is related to the ABI-FIVE BINDING PROTEIN (AFP) family, which consists of four members in Arabidopsis . NINJA acts as a transcriptional repressor through a functional TPL-binding EAR (ERF-associated amphiphilic repression) motif . This repression mechanism is crucial for regulating jasmonate-responsive gene expression.

Methodologically, understanding the protein's function informs proper experimental design when using NINJA-family protein 5 antibodies, including appropriate controls and expected cellular localization patterns.

How do NINJA proteins interact with other proteins in plant defense pathways?

NINJA proteins interact with multiple components in plant defense signaling cascades:

• NINJA interacts directly with most JAZ proteins through their conserved TIFY motif, as demonstrated through yeast two-hybrid (Y2H) screens and pull-down experiments .

• A 39-amino-acid fragment containing the TIFY motif is sufficient for binding NINJA .

• NINJA connects to the co-repressor TOPLESS through its N-terminal EAR motif .

• NINJA also interacts with other ZIM domain proteins containing the TIFY (TIF[F/Y]XG) motif, including PEAPOD 1 (PPD1), PPD2, and TIFY8 .

• NINJA forms a complex with the Groucho/Tup1-type co-repressor TPL and its homologues TPR2 and TPR3, independent of jasmonate elicitation .

These interactions form the basis for designing co-immunoprecipitation experiments with NINJA-family protein 5 antibodies.

How is NINJA protein expression regulated in different plant tissues?

NINJA proteins show tissue-specific regulation patterns that researchers should consider when designing experiments:

• While abscisic acid (ABA) induces the expression of AFP genes in Arabidopsis seedlings, NINJA expression is induced by methyl jasmonate (MeJA) within 1 hour and remains elevated for at least 12 hours after elicitation .

• NINJA-GFP fusion proteins show clear nuclear localization .

• Unlike JAZ proteins, NINJA protein levels remain constant for at least 3 hours after jasmonate treatment, suggesting its stability is unaffected by jasmonates .

• NINJA shows differential expression between root and shoot tissues. While modestly elevated JAZ10 expression (approximately 1.7 times higher than wild-type) is observed in aerial organs of ninja mutants, roots show dramatically higher expression (25 times more JAZ10 transcripts than wild-type) .

These expression patterns inform appropriate tissue collection timing and fixation protocols when using antibodies for immunohistochemistry or Western blotting.

What experimental considerations are important when using NINJA-family protein 5 antibodies for co-immunoprecipitation studies?

When designing co-immunoprecipitation (Co-IP) experiments with NINJA-family protein 5 antibodies, researchers should consider:

• Buffer composition: Since NINJA interacts with multiple proteins through specific domains, buffer conditions must preserve these interactions. The C domain of NINJA is responsible for JAZ protein interaction , while the EAR motif in domain A mediates TPL interaction .

• Crosslinking strategies: NINJA-JAZ interactions might be transient or condition-dependent. Previous studies successfully identified NINJA in protein complexes using tandem affinity purification (TAP) , suggesting this approach may be effective.

• Control experiments: Include appropriate controls such as:

  • Immunoprecipitation in ninja mutant backgrounds

  • Use of NINJA proteins with mutated interaction domains (e.g., mEAR mutants that abolish TPL interaction)

  • Comparison of samples with/without jasmonate treatment

• Validation methods: Confirm interactions using complementary techniques such as bimolecular fluorescence complementation (BiFC) as demonstrated for NINJA-TPL interactions .

• Tissue-specific considerations: Given the differential expression in roots versus shoots , carefully select tissues based on research objectives.

How can NINJA-family protein 5 antibodies be used to distinguish between different NINJA family members?

Distinguishing between NINJA family members requires careful antibody validation and experimental design:

• Epitope selection: Target unique regions that differ between NINJA family members. NINJA proteins share conserved domains A, B, and C with AFP proteins , so antibodies targeting these regions may cross-react.

• Validation strategies:

  • Test antibody specificity using recombinant proteins of different NINJA family members

  • Validate with deletion mutants lacking specific domains

  • Confirm specificity in ninja mutant lines versus wild-type

• Combined approaches:

  • Use immunoprecipitation followed by mass spectrometry to confirm the specific NINJA family member detected

  • Compare with transcript expression data to correlate protein levels with gene expression patterns

• Control experiments:

  • Include AFP family members (related to NINJA) to confirm absence of cross-reactivity

  • Use domain-specific antibodies targeting unique regions between family members

What are the technical challenges in detecting NINJA protein modifications and how can they be overcome?

Detecting post-translational modifications of NINJA proteins presents several technical challenges:

• Stability considerations: Unlike JAZ proteins, which are degraded within minutes of jasmonate application, NINJA protein levels remain stable for hours after treatment . This suggests different regulatory mechanisms that may involve:

  • Phosphorylation or other post-translational modifications

  • Conformational changes rather than degradation

  • Altered protein complex formation

• Recommended approaches:

  • Phospho-specific antibodies: Develop antibodies that specifically recognize phosphorylated forms of NINJA

  • Gel mobility shift assays: Monitor changes in NINJA migration patterns after hormone treatments

  • Mass spectrometry: Use IP with NINJA-family protein 5 antibodies followed by MS to identify modifications

• Sample preparation considerations:

  • Include phosphatase inhibitors to preserve phosphorylation states

  • Use rapid tissue harvesting and processing techniques to minimize modification changes

  • Consider subcellular fractionation to enrich for nuclear NINJA proteins

• Validation strategies:

  • Compare modifications in wild-type versus signaling mutants

  • Correlate modifications with functional assays of NINJA repressor activity

  • Use site-directed mutagenesis to confirm modification sites

What are the optimal fixation and immunohistochemistry protocols for NINJA-family protein 5 antibodies?

For successful immunohistochemistry using NINJA-family protein 5 antibodies, consider these methodological details:

• Fixation protocols:

  • For plant tissues, 4% paraformaldehyde in PBS (pH 7.4) for 2-4 hours at room temperature

  • For preserved nuclear localization (where NINJA is known to reside) , avoid overfixation which can mask epitopes

  • Consider dual fixation with glutaraldehyde for membrane preservation when examining NINJA trafficking

• Permeabilization considerations:

  • Moderate detergent treatment (0.1-0.3% Triton X-100) to ensure nuclear access

  • For thick tissues like roots (where NINJA shows strong effects) , extend permeabilization time

• Antigen retrieval:

  • Test citrate buffer (pH 6.0) heat-induced epitope retrieval

  • For plant tissues, consider cell wall digestion with enzymes like driselase or cellulase

• Signal amplification:

  • Tyramide signal amplification may help detect low-abundance NINJA proteins

  • Consider fluorescent secondary antibodies for co-localization studies with JAZ or TPL proteins

• Controls:

  • Include ninja mutant tissues as negative controls

  • Use known NINJA-GFP expressing lines as positive controls

  • Perform peptide competition assays to confirm specificity

How can NINJA-family protein 5 antibodies be used to monitor dynamic changes in protein complexes during stress responses?

Monitoring dynamic changes in NINJA-containing protein complexes during stress responses requires specialized approaches:

• Time-course experiments:

  • Based on the known methyl jasmonate (MeJA) induction pattern of NINJA , collect samples at 0, 1, 3, 6, and 12 hours post-treatment

  • Compare with JAZ protein dynamics, which degrade rapidly (within 5 minutes)

• Co-immunoprecipitation strategies:

  • Use NINJA-family protein 5 antibodies for IP at different time points after stress

  • Analyze changes in interaction partners by mass spectrometry or Western blotting

  • Compare complexes in different tissues, particularly roots versus shoots

• Proximity labeling approaches:

  • Consider BioID or TurboID fusions with NINJA to capture transient interactions

  • Compare labeled proteins before and after stress treatment

• Live cell imaging (with complementary approaches):

  • Combine antibody-based methods with fluorescently tagged proteins

  • FRET or FLIM-FRET analyses to monitor direct protein interactions in real-time

  • Correlate with functional transcriptional reporter assays for JAZ10

• Quantitative analysis:

  • Use quantitative proteomics to measure stoichiometric changes in complexes

  • Consider computational modeling of dynamic complex formation based on experimental data

What are the recommended protocols for using NINJA-family protein 5 antibodies in chromatin immunoprecipitation (ChIP) experiments?

For successful chromatin immunoprecipitation with NINJA-family protein 5 antibodies:

• Crosslinking optimization:

  • Test both 1% and 3% formaldehyde fixation times (10-20 minutes)

  • Consider dual crosslinking with disuccinimidyl glutarate (DSG) followed by formaldehyde to capture protein-protein interactions in the NINJA-JAZ-TPL complex

• Sonication parameters:

  • Optimize sonication to achieve 200-500bp fragments

  • Verify fragmentation efficiency by agarose gel electrophoresis

  • Consider using Covaris or similar systems for consistent fragmentation

• Immunoprecipitation conditions:

  • Pre-clear lysates with protein A/G beads to reduce background

  • Include appropriate blocking agents (BSA, salmon sperm DNA)

  • Consider sequential ChIP (re-ChIP) to identify genomic regions bound by both NINJA and JAZ or TPL proteins

• Controls and validation:

  • Include IgG control immunoprecipitations

  • Use ninja mutant lines as negative controls

  • Validate with known targets such as JAZ10, which shows differential expression in ninja mutants

  • Compare with ChIP using antibodies against interacting partners like TPL

• Data analysis recommendations:

  • Focus on promoters of jasmonate-responsive genes

  • Create overlap maps with known MYC2 binding sites

  • Compare NINJA binding patterns with JAZ and TPL occupancy data

Why might NINJA-family protein 5 antibodies show different results in different plant tissues?

Tissue-specific variations in NINJA antibody performance can be explained by several factors:

• Differential expression levels:

  • ninja mutants show dramatically higher JAZ10 expression in roots (25x wild-type levels) compared to aerial tissues (1.7x wild-type levels)

  • This suggests tissue-specific roles and possibly different NINJA concentrations or isoforms

• Protein complex differences:

  • NINJA forms complexes with multiple JAZ proteins and TPL/TPR co-repressors

  • The composition of these complexes likely varies between tissues

  • Different complex formation may mask or expose epitopes recognized by the antibody

• Post-translational modifications:

  • Tissue-specific modifications might affect antibody recognition

  • The nuclear localization of NINJA may be regulated differently across tissues

• Technical considerations:

  • Cell wall composition varies between tissues, affecting fixation and antibody penetration

  • Metabolite content differences may interfere with antibody binding

  • Vacuole size and distribution differ between tissues, affecting fixation efficiency

• Recommendations:

  • Validate antibodies separately for each tissue type

  • Optimize extraction buffers for different tissues

  • Consider using tissue-specific positive and negative controls

  • Validate results with complementary methods (e.g., fluorescently tagged NINJA)

How can non-specific binding be reduced when using NINJA-family protein 5 antibodies in plant protein extracts?

Reducing non-specific binding requires methodical optimization:

• Buffer optimization:

  • Test increased salt concentrations (150-500mM NaCl) to reduce ionic interactions

  • Include mild detergents (0.1% NP-40 or Triton X-100) to reduce hydrophobic interactions

  • Add competitors for non-specific binding (1-5% BSA, milk proteins, or plant-specific blocking agents)

• Pre-clearing strategies:

  • Pre-clear lysates with Protein A/G beads before adding antibodies

  • Consider pre-absorption of antibodies with extracts from ninja mutant plants

  • Use size exclusion or ion exchange chromatography to fractionate extracts before immunoprecipitation

• Antibody optimization:

  • Titrate antibody concentrations to find optimal signal-to-noise ratio

  • Consider using affinity-purified antibodies against specific NINJA epitopes

  • Test monoclonal versus polyclonal antibodies for differential specificity

• Validation approaches:

  • Always include appropriate negative controls (ninja mutants, pre-immune serum)

  • Confirm specificity through peptide competition assays

  • Validate detected bands by mass spectrometry

• Special considerations for plant extracts:

  • Include PVP or PVPP to remove phenolic compounds

  • Add protease inhibitors optimized for plant proteases

  • Consider removing abundant proteins (like RuBisCO) that may cause background

What are the common pitfalls when quantifying NINJA protein levels using antibody-based methods?

When quantifying NINJA protein levels, researchers should be aware of these common pitfalls:

How can NINJA-family protein 5 antibodies be used to study the role of NINJA in cross-talk between jasmonate and other hormone signaling pathways?

NINJA proteins are positioned at the intersection of multiple hormone signaling pathways, making NINJA-family protein 5 antibodies valuable tools for studying signaling cross-talk:

• Co-immunoprecipitation approaches:

  • Perform IPs with NINJA antibodies before and after treatment with multiple hormones

  • Compare NINJA interaction partners after treatment with jasmonate, abscisic acid, auxin, or combinations

  • Look for differential complex formation that might explain synergistic or antagonistic effects

• ChIP-seq applications:

  • Map NINJA binding sites genome-wide under different hormone treatments

  • Identify genes where NINJA occupancy changes in response to multiple signals

  • Compare with binding sites of other hormone-responsive transcription factors

• Comparative studies with related proteins:

  • NINJA is related to ABI-FIVE BINDING PROTEIN (AFP) family involved in ABA signaling

  • Compare NINJA and AFP protein interactions under different hormone treatments

  • Examine competition or cooperation between pathway components

• Genetic background variations:

  • Use NINJA antibodies in hormone signaling mutant backgrounds

  • Compare NINJA complex formation in wild-type versus hormone biosynthesis or perception mutants

  • Study NINJA complexes in mutants with enhanced or reduced crosstalk phenotypes

• Developmental context:

  • Given the strong effects of NINJA in roots , examine tissue-specific aspects of hormone crosstalk

  • Analyze NINJA complexes at different developmental stages to identify context-dependent interactions

What are the best approaches for studying NINJA interactions with JAZ and TOPLESS proteins using antibody-based methods?

Studying the tripartite NINJA-JAZ-TOPLESS complex requires specialized approaches:

• Sequential immunoprecipitation:

  • First IP with NINJA antibody followed by elution and second IP with JAZ or TPL antibodies

  • This approach can isolate intact complexes containing all three components

  • Compare complex composition before and after jasmonate treatment

• Proximity-based approaches:

  • Use antibodies in combination with proximity ligation assays (PLA)

  • This can visualize direct interactions between NINJA and JAZ or TPL proteins in situ

  • Quantify interaction signals in different cell types or after hormone treatments

• Domain-specific studies:

  • NINJA interacts with JAZ through its C domain and with TPL through its EAR motif in domain A

  • Use antibodies against specific domains to study mutually exclusive or cooperative binding

  • Compare wild-type with point mutants (e.g., NINJA mEAR that abolishes TPL binding)

• Stoichiometry analysis:

  • Use quantitative Western blotting with domain-specific antibodies

  • Determine the relative abundance of different complex components

  • Study how stoichiometry changes during signal transduction

• Functional correlation:

  • Combine interaction studies with transcriptional reporter assays

  • Correlate changes in complex formation with repression activity

  • Use JAZ10 expression, a known target elevated in ninja mutants , as a functional readout

How can NINJA-family protein 5 antibodies be integrated with other molecular tools to study plant immune responses?

Integrating NINJA-family protein 5 antibodies with complementary molecular tools provides powerful insights into plant immunity:

• Multi-omics integration:

  • Combine antibody-based proteomics with transcriptomics to correlate NINJA complex formation with gene expression changes

  • Integrate with metabolomics to link NINJA activity to production of defense compounds

  • Use phosphoproteomics to identify signaling events upstream and downstream of NINJA

• CRISPR-based approaches:

  • Use NINJA antibodies to study protein interactions in CRISPR-edited plants with modified JAZ binding sites or EAR motifs

  • Compare wild-type NINJA with engineered variants to understand structure-function relationships

  • Create synthetic circuits with modified NINJA proteins and monitor activity with antibodies

• Pathogen challenge studies:

  • Monitor NINJA complex dynamics during pathogen infection

  • Compare NINJA-JAZ-TPL complex formation after PAMP treatment versus effector delivery

  • Study the relationship between NINJA and ERF19, which negatively regulates Arabidopsis pattern-triggered immunity

• Single-cell approaches:

  • Use immunofluorescence with NINJA antibodies for single-cell analysis of immune responses

  • Combine with cell-type specific markers to identify cell populations with unique NINJA activity profiles

  • Correlate with single-cell transcriptomics data

• Systems biology integration:

  • Use antibody-derived interaction data to build mathematical models of immune signaling networks

  • Test model predictions by monitoring NINJA complex dynamics under various perturbations

  • Compare model parameters between resistant and susceptible plant varieties